These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Image-guided radiofrequency ablation of hepatocellular carcinoma (HCC): is MR guidance more effective than CT guidance? Clasen S; Rempp H; Hoffmann R; Graf H; Pereira PL; Claussen CD Eur J Radiol; 2014 Jan; 83(1):111-6. PubMed ID: 24161781 [TBL] [Abstract][Full Text] [Related]
5. Radiofrequency ablation of liver metastases-software-assisted evaluation of the ablation zone in MDCT: tumor-free follow-up versus local recurrent disease. Keil S; Bruners P; Schiffl K; Sedlmair M; Mühlenbruch G; Günther RW; Das M; Mahnken AH Cardiovasc Intervent Radiol; 2010 Apr; 33(2):297-306. PubMed ID: 19688366 [TBL] [Abstract][Full Text] [Related]
6. Effectiveness and safety in radiofrequency ablation of pulmonary metastases from HCC: a five years study. Lassandro G; Picchi SG; Bianco A; Di Costanzo G; Coppola A; Ierardi AM; Lassandro F Med Oncol; 2020 Mar; 37(4):25. PubMed ID: 32166529 [TBL] [Abstract][Full Text] [Related]
7. Small liver colorectal metastases treated with percutaneous radiofrequency ablation: local response rate and long-term survival with up to 10-year follow-up. Solbiati L; Ahmed M; Cova L; Ierace T; Brioschi M; Goldberg SN Radiology; 2012 Dec; 265(3):958-68. PubMed ID: 23091175 [TBL] [Abstract][Full Text] [Related]
8. Clinical Outcomes and Predictors in Patients With Unresectable Colorectal Cancer Liver Metastases Following Salvage Percutaneous Radiofrequency Ablation: A Single Center Preliminary Experience. Wang Y; Zhang GY; Xu LC; He XH; Huang HZ; Li GD; Wang YH; Wang GZ; Li WT Technol Cancer Res Treat; 2020; 19():1533033820963662. PubMed ID: 33034276 [TBL] [Abstract][Full Text] [Related]
9. Comparison of FDG-PET, PET/CT and MRI for follow-up of colorectal liver metastases treated with radiofrequency ablation: initial results. Kuehl H; Antoch G; Stergar H; Veit-Haibach P; Rosenbaum-Krumme S; Vogt F; Frilling A; Barkhausen J; Bockisch A Eur J Radiol; 2008 Aug; 67(2):362-371. PubMed ID: 18155866 [TBL] [Abstract][Full Text] [Related]
10. Image-guided microwave ablation of hepatocellular carcinoma (≤5.0 cm): is MR guidance more effective than CT guidance? Li Z; Wang C; Si G; Zhou X; Li Y; Li J; Jiao D; Han X BMC Cancer; 2021 Apr; 21(1):366. PubMed ID: 33827464 [TBL] [Abstract][Full Text] [Related]
11. CT-guided radiofrequency ablation prolonged metastatic survival in patients with liver metastases from nasopharyngeal carcinoma. Pan C; Wu P; Yu J; Li W; Huang Z; He N; Wang J; Zhao M Int J Hyperthermia; 2011; 27(6):549-54. PubMed ID: 21846191 [TBL] [Abstract][Full Text] [Related]
12. Salvage RFA in patients with intrahepatic recurrence after major hepatic surgery for colorectal cancer liver metastases: mid-term outcome. Zimmermann M; Pedersoli F; Schulze-Hagen M; Lurje G; Isfort P; Kuhl C; Bruners P Eur Radiol; 2020 Feb; 30(2):1221-1227. PubMed ID: 31493210 [TBL] [Abstract][Full Text] [Related]
13. Local Tumor Progression Predictive Model Based on MRI for Colorectal Cancer Liver Metastases after Radiofrequency Ablation. Zhang G; Liu P; Wang G; He X; Xu L; Wang Y; Li W; Peng W Discov Med; 2024 Apr; 36(183):765-777. PubMed ID: 38665025 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of ultrasound-, computed tomography-, and magnetic resonance imaging-guided radiofrequency ablation for hepatocellular carcinoma. Yuan C; Yuan Z; Cui X; Gao W; Zhao P; He N; Cui S; Wang Y; Zhang Y; Li W; Zheng J J Cancer Res Ther; 2019; 15(4):784-792. PubMed ID: 31436232 [TBL] [Abstract][Full Text] [Related]
15. Comparison of Microwave and Radiofrequency Ablation for the Treatment of Small- and Medium-Sized Hepatocellular Carcinomas in a Prospective Randomized Trial. Vogl TJ; Martin SS; Gruber-Rouh T; Booz C; Koch V; Nour-Eldin NA; Hussainy Said MN Rofo; 2024 May; 196(5):482-490. PubMed ID: 38065541 [TBL] [Abstract][Full Text] [Related]
16. Percutaneous radiofrequency ablation for small hepatocellular carcinoma in hepatic dome under MR-guidance: clinical safety and efficacy. Chen J; Lin Z; Lin Q; Lin R; Yan Y; Chen J Int J Hyperthermia; 2020; 37(1):192-201. PubMed ID: 32066293 [No Abstract] [Full Text] [Related]
17. Real-time US-CT/MR fusion imaging for percutaneous radiofrequency ablation of hepatocellular carcinoma. Ahn SJ; Lee JM; Lee DH; Lee SM; Yoon JH; Kim YJ; Lee JH; Yu SJ; Han JK J Hepatol; 2017 Feb; 66(2):347-354. PubMed ID: 27650284 [TBL] [Abstract][Full Text] [Related]
18. Radiofrequency ablation for treating liver metastases from a non-colorectal origin. Yun BL; Lee JM; Baek JH; Kim SH; Lee JY; Han JK; Choi BI Korean J Radiol; 2011; 12(5):579-87. PubMed ID: 21927559 [TBL] [Abstract][Full Text] [Related]
19. Does the Site of the Primary Affect Outcomes When Ablating Colorectal Liver Metastases with Radiofrequency Ablation? Gu Y; Huang Z; Gu H; Gao F; Zhang T; Huang S; Huang J Cardiovasc Intervent Radiol; 2018 Jun; 41(6):912-919. PubMed ID: 29582125 [TBL] [Abstract][Full Text] [Related]
20. Retrospective review of efficacy of radiofrequency ablation for treatment of colorectal cancer liver metastases from a Canadian perspective. Kwan BY; Kielar AZ; El-Maraghi RH; Garcia LM Can Assoc Radiol J; 2014 Feb; 65(1):77-85. PubMed ID: 22867961 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]